A detailed history of Fulton Breakefield Broenniman LLC transactions in Danaher Corp stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 99,755 shares of DHR stock, worth $20.3 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
99,755
Previous 99,670 0.09%
Holding current value
$20.3 Million
Previous $27.7 Million 17.36%
% of portfolio
1.66%
Previous 1.97%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$226.16 - $274.52 $19,223 - $23,334
85 Added 0.09%
99,755 $22.9 Million
Q3 2024

Oct 16, 2024

SELL
$239.25 - $280.76 $413,663 - $485,434
-1,729 Reduced 1.71%
99,670 $27.7 Million
Q2 2024

Aug 07, 2024

SELL
$235.51 - $267.98 $97,972 - $111,479
-416 Reduced 0.41%
101,399 $25.3 Million
Q1 2024

Apr 29, 2024

SELL
$224.58 - $256.19 $138,790 - $158,325
-618 Reduced 0.6%
101,815 $25.4 Million
Q4 2023

Feb 02, 2024

BUY
$185.1 - $233.13 $74,780 - $94,184
404 Added 0.4%
102,433 $23.7 Million
Q3 2023

Oct 20, 2023

BUY
$233.08 - $265.59 $115,607 - $131,732
496 Added 0.49%
102,029 $25.3 Million
Q2 2023

Jul 19, 2023

BUY
$224.99 - $256.14 $432,205 - $492,044
1,921 Added 1.93%
101,533 $24.4 Million
Q1 2023

Apr 25, 2023

BUY
$239.75 - $277.0 $461,758 - $533,502
1,926 Added 1.97%
99,612 $25.1 Million
Q4 2022

Jan 31, 2023

BUY
$241.42 - $282.29 $444,937 - $520,260
1,843 Added 1.92%
97,686 $25.9 Million
Q3 2022

Oct 17, 2022

SELL
$247.06 - $1507.4 $53,364 - $325,598
-216 Reduced 0.22%
95,843 $24.8 Million
Q2 2022

Jul 28, 2022

SELL
$237.11 - $299.66 $13,752 - $17,380
-58 Reduced 0.06%
96,059 $24.4 Million
Q1 2022

Apr 27, 2022

BUY
$257.27 - $315.76 $976,596 - $1.2 Million
3,796 Added 4.11%
96,117 $28.2 Million
Q4 2021

Feb 07, 2022

BUY
$292.08 - $329.01 $191,020 - $215,172
654 Added 0.71%
92,321 $30.4 Million
Q3 2021

Oct 25, 2021

SELL
$272.21 - $332.43 $3.94 Million - $4.81 Million
-14,478 Reduced 13.64%
91,667 $27.9 Million
Q2 2021

Jul 27, 2021

BUY
$225.08 - $271.69 $507,105 - $612,117
2,253 Added 2.17%
106,145 $28.5 Million
Q1 2021

Apr 09, 2021

BUY
$212.38 - $245.9 $3.67 Million - $4.25 Million
17,273 Added 19.94%
103,892 $23.4 Million
Q4 2020

Jan 14, 2021

SELL
$212.5 - $245.46 $2.88 Million - $3.33 Million
-13,563 Reduced 13.54%
86,619 $19.2 Million
Q3 2020

Oct 20, 2020

BUY
$177.16 - $215.33 $97,260 - $118,216
549 Added 0.55%
100,182 $21.6 Million
Q2 2020

Jul 10, 2020

BUY
$128.7 - $176.83 $505,662 - $694,765
3,929 Added 4.11%
99,633 $17.6 Million
Q1 2020

Apr 10, 2020

BUY
$121.39 - $169.05 $230,641 - $321,195
1,900 Added 2.03%
95,704 $13.2 Million
Q4 2019

Jan 14, 2020

BUY
$133.47 - $153.48 $46,714 - $53,718
350 Added 0.37%
93,804 $14.4 Million
Q3 2019

Oct 17, 2019

BUY
$135.4 - $146.47 $74,605 - $80,704
551 Added 0.59%
93,454 $13.5 Million
Q2 2019

Jul 25, 2019

BUY
$124.88 - $143.73 $371,018 - $427,021
2,971 Added 3.3%
92,903 $13.3 Million
Q1 2019

Apr 17, 2019

SELL
$97.62 - $132.29 $122,805 - $166,420
-1,258 Reduced 1.38%
89,932 $11.9 Million
Q4 2018

Feb 05, 2019

SELL
$94.85 - $109.54 $71,422 - $82,483
-753 Reduced 0.82%
91,190 $9.4 Million
Q3 2018

Oct 24, 2018

BUY
$98.13 - $108.9 $42,980 - $47,698
438 Added 0.48%
91,943 $9.99 Million
Q2 2018

Aug 02, 2018

BUY
$96.1 - $103.24 $170,481 - $183,147
1,774 Added 1.98%
91,505 $9.03 Million
Q1 2018

Apr 19, 2018

SELL
$92.16 - $103.8 $75,294 - $84,804
-817 Reduced 0.9%
89,731 $8.79 Million
Q4 2017

Jan 30, 2018

SELL
$85.26 - $94.62 $33,166 - $36,807
-389 Reduced 0.43%
90,548 $8.41 Million
Q3 2017

Oct 13, 2017

BUY
$79.29 - $88.45 $7.21 Million - $8.04 Million
90,937
90,937 $7.8 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $148B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Fulton Breakefield Broenniman LLC Portfolio

Follow Fulton Breakefield Broenniman LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.